Honours pharma companies with Outstanding Export Performance Award
Pharmaceuticals Export Promotion Council of India (Pharmexcil) recently organised the 9th Edition of Outstanding Export Performance Award in Hyderabad.
InnoCare announced the first patient dosed in the Phase III trial of ICP-248 combined with orelabrutinib for CLL/SLL. It's a potential treatment, with other trials advancing.